INNOGENE Co.,Ltd. (KOSDAQ:344860)

INNOGENE Revenue

INNOGENE had revenue of 2.59B KRW in the quarter ending March 31, 2026, with 46.59% growth. This brings the company's revenue in the last twelve months to 9.04B, up 4.20% year-over-year. In the year 2025, INNOGENE had annual revenue of 8.21B, down -8.17%.

• Revenue (ttm): 9.04B
• Revenue Growth: +4.20%
• P/S Ratio: 1.89
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 17.06B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.21B	-731.15M	-8.17%
Dec 31, 2024	8.94B	-1.16B	-11.45%
Dec 31, 2023	10.10B	961.65M	10.52%
Dec 31, 2022	9.14B	-245.63M	-2.62%
Dec 31, 2021	9.39B	3.74B	66.29%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 30, 2026

Data Sources Report a data error